↓ Skip to main content

Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis

Overview of attention for article published in BMC Research Notes, August 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

policy
1 policy source
twitter
6 X users
facebook
1 Facebook page

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
74 Mendeley